Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients After Hematopoietic Stem Cell Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00928018
What this trial is testing

Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma

Who this might be right for
Non-hodgkin LymphomaHodgkin Lymphoma
Dana-Farber Cancer Institute 139
Testing effectiveness (Phase 2)Study completedNCT00467961
What this trial is testing

Stem Cell Transplantation for Patients With Cancers of the Blood

Who this might be right for
CML (Chronic Myelogenous Leukemia)CLL (Chronic Lymphocytic Leukemia)AML (Acute Myelogenous Leukemia)+2 more
National Heart, Lung, and Blood Institute (NHLBI) 61
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05554419
What this trial is testing

Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia Following Initial Treatment, The ERASE Study (A MyeloMATCH Treatment Trial)

Who this might be right for
Acute Myeloid LeukemiaAcute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeAcute Myeloid Leukemia Arising From Previous Myeloproliferative Neoplasm+2 more
National Cancer Institute (NCI)
Not applicableStudy completedNCT04038827
What this trial is testing

Origin of CEC in Patients After Allo-HSCT

Who this might be right for
Graft Versus Host Disease, AcuteEndothelial DysfunctionImmune Tolerance
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 15
Testing effectiveness (Phase 2)Study completedNCT02400255
What this trial is testing

Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients

Who this might be right for
Acute Myeloid Leukemia
Arog Pharmaceuticals, Inc. 30
Not applicableLooking for participantsNCT06267781
What this trial is testing

RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies

Who this might be right for
Multiple Sclerosis
IRCCS San Raffaele 30
Not applicableUnknownNCT05596981
What this trial is testing

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAllogeneic Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 60
Testing effectiveness (Phase 2)Study completedNCT01919619
What this trial is testing

Lenalidomide and Ipilimumab After Stem Cell Transplant in Treating Patients With Hematologic or Lymphoid Malignancies

Who this might be right for
B-Cell Non-Hodgkin LymphomaHematopoietic and Lymphoid Cell NeoplasmLeukemia+3 more
M.D. Anderson Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT00309907
What this trial is testing

Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaBlastic Phase Chronic Myelogenous LeukemiaChildhood Acute Lymphoblastic Leukemia in Remission+22 more
Children's Oncology Group 39
Testing effectiveness (Phase 2)Ended earlyNCT03622775
What this trial is testing

Daratumumab in Treating Participants With Relapsed Multiple Myeloma After Stem Cell Transplant

Who this might be right for
Recurrent Plasma Cell Myeloma
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT04099901
What this trial is testing

Anakinra: Efficacy in the Management of Fever During Neutropenia and Mucositis in ASCT - A Randomized Controlled Trial

Who this might be right for
Multiple Myeloma
Radboud University Medical Center 88
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07197112
What this trial is testing

Study of Gecacitinib in the Treatment of Acute Graft-Versus-Host Disease After Failure of Ruxolitinib-containing Second-line Therapy

Who this might be right for
Acute Graft Versus Host Disease Grade II-IVAcute Graft vs Host Disease
Ruijin Hospital 15
Early research (Phase 1)UnknownNCT00517907
What this trial is testing

Safety Study of Preimplantation Factor (PIF-1) to Treat Acute Steroid-Resistant Graft-Versus-Host Disease (GVHD)

Who this might be right for
Graft Vs Host Disease
Hadassah Medical Organization 6
Testing effectiveness (Phase 2)Study completedNCT00599547
What this trial is testing

Allogeneic Stem Cell Transplantation (SCT) After Dose-reduced Conditioning for Myelofibrosis Patients

Who this might be right for
Myelofibrosis
Universitätsklinikum Hamburg-Eppendorf 106
Early research (Phase 1)Study completedNCT00561418
What this trial is testing

Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma

Who this might be right for
LymphomaSmall Intestine Cancer
Ohio State University Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT01131169
What this trial is testing

Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post Transplantation Donor Lymphocyte Infusions

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 66
Testing effectiveness (Phase 2)Ended earlyNCT05984199
What this trial is testing

Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Leukemia, Myeloid, Acute
Vor Biopharma 38
Testing effectiveness (Phase 2)Ended earlyNCT03367546
What this trial is testing

Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases

Who this might be right for
Sickle Cell DiseaseThalassemiaHigh Risk Hematologic Disorders+2 more
Masonic Cancer Center, University of Minnesota 5
Early research (Phase 1)Study completedNCT00288028
What this trial is testing

Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Barbara Ann Karmanos Cancer Institute 15
Not applicableStudy completedNCT01714570
What this trial is testing

Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia

Who this might be right for
FebrileNeutropeniaHematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 123
Next Page
184